| Fri, 27 Mar 2020 13:45:58: | Preventing Type 1 diabetes by deleting a stress response gene
|
| Fri, 27 Mar 2020 12:32:49: | Vertex guns for virtual trials but hits pause, sees delays for 'some new study starts'
|
| Fri, 27 Mar 2020 11:09:24: | Big Pharma companies join forces for fightback against COVID-19
|
| Fri, 27 Mar 2020 10:21:55: | FDA moots virtual AdComms but delays GSK, Intercept meetings
|
| Fri, 27 Mar 2020 08:36:47: | In conversation with: Science 37 and the response to COVID-19
|
| Fri, 27 Mar 2020 08:15:43: | U.K. government-backed medical research shut down amid COVID-19
|
| Thu, 26 Mar 2020 13:08:20: | COVID-19 prompts Pfizer to stop enrollment in most studies
|
| Thu, 26 Mar 2020 13:04:44: | Safely overcoming resistance to checkpoint inhibition in cancer by blocking a growth factor
|
| Thu, 26 Mar 2020 12:59:03: | Chutes & Ladders—Urovant brings on Astellas alum Robinson as CEO
|
| Thu, 26 Mar 2020 12:32:47: | Ipsen scraps pivotal trial as partial clinical hold drags on
|
| Thu, 26 Mar 2020 08:57:14: | Cancer biotech Viracta nabs Nordic Nanovector exec as CMO
|
| Wed, 25 Mar 2020 19:03:44: | Roche forges antibiotics pact as it sees beyond COVID-19 threats to public health
|
| Wed, 25 Mar 2020 18:01:29: | PRA Health Sciences unveils COVID-19 monitoring app to track symptoms
|
| Wed, 25 Mar 2020 12:39:07: | Scangos' Vir Biotechnology to test COVID-19 antibody 'in the summer'
|
| Wed, 25 Mar 2020 10:40:23: | Astra, Daiichi's Enhertu shows early promise in HER2 lung cancer
|
| Wed, 25 Mar 2020 10:13:04: | China biotech Laekna snaps up Novartis PD-L1 cancer therapy
|
| Wed, 25 Mar 2020 09:55:10: | AstraZeneca pays Silence $60M to take siRNA beyond the liver
|
| Wed, 25 Mar 2020 07:41:29: | Redpin bags A round to advance Chantix-controlled gene therapies
|
| Tue, 24 Mar 2020 12:42:42: | Novavax flu vaccine matches and beats Sanofi rival in phase 3
|
| Tue, 24 Mar 2020 10:57:55: | Embattled Cel-Sci to tackle COVID-19 with immunotherapy platform tech LEAPS
|
| Tue, 24 Mar 2020 10:50:22: | CytomX pens $1.6B Astellas biobucks pact for T-cell R&D
|
| Tue, 24 Mar 2020 08:24:48: | U.K. gov backs push to start COVID-19 vaccine trial in April
|
| Mon, 23 Mar 2020 13:16:50: | AlloVir, Baylor ally to develop COVID-19 T-cell therapy
|
| Mon, 23 Mar 2020 13:09:08: | AbbVie-backed Carisma's 'CAR-M' tech shrinks tumors in mouse models of ovarian cancer
|
| Mon, 23 Mar 2020 11:50:19: | Lilly slashes clinical trial activities in response to COVID-19
|
